| 30-day mortality | |||||
---|---|---|---|---|---|---|
ICU admission day 1 | ICU admission day 2 | |||||
Survivors (n = 52) | Nonsurvivors (n = 15) | P-value | Survivors (n = 52) | Nonsurvivors (n = 15) | P value | |
White blood cell (/μL) | 10,346 ± 5830 (8990, 400–25,630) | 13,549 ± 7284 (12,000, 4510–33,900) | 0.0810 | 11,433 ± 5106 (10,845, 740–27,740) | 13,577 ± 8145 (12,150, 6470–39,990) | 0.4890 |
Hemoglobin (g/dL) | 10.5 ± 2.2 (10.9, 5.8–13.8) | 10.5 ± 2.2 (10.1, 7.7–16.0) | 0.6572 | 10.2 ± 1.7 (10.5, 6.8–14.0) | 10.3 ± 2.3 (10.2, 5.6–13.9) | 0.9281 |
Platelet (× 103/μL) | 178 ± 120 (137, 25–567) | 113 ± 93 (111, 20–371) | 0.0365 | 159 ± 110 (126, 16–586) | 98 ± 63 (97, 11–211) | 0.0446 |
C-reactive protein (mg/dL) | 6.3 ± 7.6 (3.9, 0.01–28.7) | 11.6 ± 15.0 (7.1, 0.1–51.0) | 0.1552 | 10.1 ± 8.0 (9.3, 0.06–27.0) | 11.6 ± 15.2 (7.3, 0.2–58.3) | 0.6410 |
Total protein (g/dL) | 6.0 ± 1.1 (6.3, 3.7–8.0) | 5.0 ± 1.3 (4.8, 2.0–7.3) | 0.0063 | 5.5 ± 0.9 (5.6, 3.3–7.1) | 5.0 ± 0.8 (4.8, 4.0–6.4) | 0.0540 |
Albumin (g/dL) | 3.2 ± 0.8 (3.3, 1.4–4.6) | 2.4 ± 0.8 (2.3, 0.7–3.8) | 0.0016 | 3.0 ± 0.7 (2.9, 1.5–5.0) | 2.7 ± 0.6 (2.8, 1.8–3.7) | 0.3947 |
Blood urea nitrogen (mg/dL) | 27.9 ± 18.0 (22, 4–95) | 44.6 ± 34.7 (35, 2–118) | 0.0758 | 28.8 ± 17.8 (24, 10–77) | 46.5 ± 30.3 (37, 6–116) | 0.0139 |
Creatinine (mg/dL) | 1.5 ± 1.5 (0.9, 0.4–7.6) | 2.5 ± 2.4 (1.9, 0.6–10.0) | 0.0665 | 1.4 ± 1.2 (0.9, 0.3–5.1) | 2.3 ± 1.6 (1.8, 0.7–6.3) | 0.0101 |
Total bilirubin (mg/dL) | 0.9 ± 0.7 (0.8, 0.1–4.1) | 3.6 ± 4.5 (0.9, 0.2–12.7) | 0.4973 | 1.1 ± 0.9 (0.9, 0.2–4.8) | 3.7 ± 4.4 (1.4, 0.2–12.1) | 0.1398 |
Lactate dehydrogenase (U/L) | 367.3 ± 249.6 (314, 112–1439) | 506.3 ± 413.7 (409, 206–1953) | 0.1011 | 348.8 ± 166.4 (312, 100–837) | 604.0 ± 583.9 (424, 189–2159) | 0.1027 |
PT-INR | 1.2 ± 0.2 (1.1, 0.9–2.2) | 1.7 ± 1.0 (1.5, 1.1–5.0) | 0.0003 | 1.2 ± 0.5 (1.1, 0.9–4.2) | 1.4 ± 0.4 (1.2, 1.0–2.7) | 0.0171 |